These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25523634)

  • 1. Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trial.
    Polosa R; Bellinvia S; Caruso M; Emma R; Alamo A; Kowalski ML; Domingo C
    Trials; 2014 Dec; 15():492. PubMed ID: 25523634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term effect of methotrexate in severe steroid-dependent asthma.
    Kanzow G; Nowak D; Magnussen H
    Lung; 1995; 173(4):223-31. PubMed ID: 7564481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single, high-dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: a double-blind study.
    Ogirala RG; Sturm TM; Aldrich TK; Meller FF; Pacia EB; Keane AM; Finkel RI
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1461-6. PubMed ID: 7582277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of acupuncture for chronic asthma: study protocol for a randomized controlled trial.
    Yin LM; Wang Y; Fan L; Xu YD; Wang WQ; Liu YY; Feng JT; Hu CP; Wang PY; Zhang TF; Shao SJ; Yang YQ
    Trials; 2015 Sep; 16():424. PubMed ID: 26399399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.
    Busard CI; Menting SP; van Bezooijen JS; van den Reek JM; Hutten BA; Prens EP; de Jong EM; van Doorn MB; Spuls PI
    Trials; 2017 Feb; 18(1):52. PubMed ID: 28148280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
    Lock SH; Kay AB; Barnes NC
    Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD;
    Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids.
    Domingo C; Moreno A; Mirapeix R
    Intern Med J; 2011 Jul; 41(7):525-36. PubMed ID: 21762333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial.
    Todi VK; Lodha R; Kabra SK
    Arch Dis Child; 2010 Jul; 95(7):540-3. PubMed ID: 20522464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study.
    Mease PJ; Gladman DD; Keystone EC;
    Arthritis Rheum; 2006 May; 54(5):1638-45. PubMed ID: 16646026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial.
    Jaimes-Hernández J; Meléndez-Mercado CI; Mendoza-Fuentes A; Aranda-Pereira P; Castañeda-Hernández G
    Reumatol Clin; 2012; 8(5):243-9. PubMed ID: 22763150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
    Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
    Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity.
    Goodkin DE; Rudick RA; VanderBrug Medendorp S; Greene T; Schwetz KM; Fischer J; Daughtry MM; Ross J; Van Dyke C
    Online J Curr Clin Trials; 1992 Sep; Doc No 19():[7723 words; 89 paragraphs]. PubMed ID: 1343611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma.
    American Lung Association Asthma Clinical Research Centers
    Am J Respir Crit Care Med; 2007 Feb; 175(3):235-42. PubMed ID: 16998094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J; Cabrera P; Berkman N; Buhl R; Holgate S; Wenzel S; Fox H; Hedgecock S; Blogg M; Cioppa GD
    Allergy; 2005 Mar; 60(3):302-8. PubMed ID: 15679714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy.
    Corrigan CJ; Shiner RJ; Shakur BH; Ind PW
    Clin Exp Allergy; 2005 May; 35(5):579-84. PubMed ID: 15898978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oral pulse methotrexate with placebo in the treatment of severe glucocorticosteroid-dependent asthma.
    Stewart GE; Diaz JD; Lockey RF; Seleznick MJ; Trudeau WL; Ledford DK
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):482-9. PubMed ID: 8083453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.